Skip to main content
. 2021 Apr 17;3(2):dlab048. doi: 10.1093/jacamr/dlab048

Table 4.

Factors related to treatment outcomesa

Factors Treatment success, n (%) Treatment failure, n (%) P value
Age
 ≥65 years old 66 (75.0) 22 (25.0) 0.042b
 <65 years old 42 (91.3) 4 (8.7)
Gender
 male 49 (74.2) 17 (25.8) 0.107
 female 59 (86.8) 9 (13.2)
Initial eGFRc
 ≥60 mL/min/1.73 m2 36 (87.8) 5 (12.2) 0.213
 <60 mL/min/1.73 m2 69 (76.7) 21 (23.3)
Department of treatment
 ICU 2 (11.1) 16 (88.9) <0.001b
 infectious diseases department 69 (98.6) 1 (1.4)
 others 37 (80.4) 9 (19.6)
Presence of septic shock
 no 103 (90.4) 11 (9.6) <0.001b
 yes 5 (25.0) 15 (75.0)
Site of infectiond
 unknown 27 (90.0) 3 (10.0) <0.001b
 urinary 35 (92.1) 3 (7.9)
 intra-abdominal 21 (80.8) 5 (19.2)
 respiratory 9 (40.9) 13 (59.1)
 skin and soft tissue 14 (87.5) 2 (12.5)
Blood culturee
 positive 42 (79.2) 11 (20.8) 0.739
 negative 55 (83.3) 11 (16.7)
Appropriate empirical antimicrobial agentsf
 yes 58 (79.5) 15 (20.5) 0.874
 no 46 (82.1) 10 (17.9)
Appropriate dosage (in 73 patients who received appropriate antibiotic agents)
 yes 30 (96.8) 1 (3.2) 0.004b
 no 28 (66.7) 14 (33.3)
Overallf
 appropriate 29 (96.7) 1 (3.3) 0.023b
 inappropriate 75 (75.8) 24 (24.2)
a

Based on χ2 test and/or Fisher’s exact test.

b

Statistically significant at 95% CI.

c

Three patients did not have laboratory tests related to serum creatinine, thus we could calculate eGFR values of only the 131 remaining patients.

d

Two patients with sepsis that originated from other sites of infection were excluded from the analysis.

e

The blood cultures were only collected from 119 patients.

f

Empirical antimicrobial therapy were assessed in 129 patients whose microbiological tests were not available at the time of administering antibiotics; 5 other patients were prescribed targeted antimicrobial therapy.